Context Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNTX and other ETFs, options, and stocks.

About CNTX

Context Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is dedicated to improving the lives of women living with cancer. It engages in developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and gynecological cancers. 

CEO
Martin A. Lehr
CEOMartin A. Lehr
Employees
7
Employees7
Headquarters
Philadelphia, Pennsylvania
HeadquartersPhiladelphia, Pennsylvania
Founded
2015
Founded2015
Employees
7
Employees7

CNTX Key Statistics

Market cap
18.04M
Market cap18.04M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
311.95K
Average volume311.95K
High today
$1.18
High today$1.18
Low today
$1.12
Low today$1.12
Open price
$1.12
Open price$1.12
Volume
155.34K
Volume155.34K
52 Week high
$10.87
52 Week high$10.87
52 Week low
$1.06
52 Week low$1.06

CNTX Earnings

-$0.30
-$0.20
-$0.10
$0.00
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 10, After Hours
ActualExpected Nov 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.